Table 4.
The number of subjects who experienced a percent reduction from the baseline IOP in patients with normal tension glaucoma and subgroups
| Percent reduction after 12 weeks in mean IOP from baseline |
No of subjects (%)
|
P value (Pearson χ2 test) | |
| Tafluprost (n = 90) | Travoprost (n = 90) | ||
|
| |||
| ≧10% | 65 (72.2) | 56 (62.2) | 0.132 |
| ≧20% | 33 (36.7) | 32 (35.5) | 0.859 |
| ≧30% | 7 (7.8) | 5 (5.5) | 0.513 |
|
| |||
| Tafluprost (highteens group: n = 57) | Travoprost (highteens group: n = 54) | ||
|
| |||
| ≧10% | 43 (75.4) | 37 (68.5) | 0.277 |
| ≧20% | 26 (45.6) | 23 (42.6) | 0.669 |
| ≧30% | 6 (10.5) | 3 (5.6) | 0.202 |
|
| |||
| Tafluprost (lowteens group: n = 33) | Travoprost (lowteens group: n = 36) | ||
|
| |||
| ≧10% | 22 (66.7) | 19 (52.8) | 0.045** |
| ≧20% | 7 (21.2) | 9 (25.0) | 0.523 |
| ≧30% | 1 (3.0) | 2 (5.6) | 0.365 |
Notes: The patients in highteens group were defined as the baseline intraocular pressure of ≦15 mmHg. The patients in lowteens group were defined as the baseline intraocular pressure of <15 mmHg.
Abbreviation: IOP, intraocular pressure.